Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio

Conclusions: Rates of TOE/death were not influenced by aPL results at baseline or follow-up. Persistent anti-β2GPI alone, and with persistent second aPL, was independently associated with decreased time to TOE/death. Persistent aPL, an aPL portfolio and newer aPL in ischemic stroke patients are not helpful in predicting an increased rate of recurrent TOEs.Cerebrovasc Dis 2015;40:293-300
Source: Cerebrovascular Diseases - Category: Neurology Source Type: research